The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 12, 2021
Filed:
Aug. 01, 2019
Applicant:
Stingray Therapeutics, Inc., Houston, TX (US);
Inventors:
Hariprasad Vankayalapati, Draper, UT (US);
Sunil Sharma, Phoenix, AZ (US);
Mohan Rao Kaadige, Scottdale, AZ (US);
Alexis Weston, Phoenix, AZ (US);
Trason Thode, Phoenix, AZ (US);
Assignee:
STINGRAY THERAPEUTICS, INC., Houston, TX (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); A61P 35/00 (2006.01); A61K 9/00 (2006.01); A61K 47/26 (2006.01); A61K 47/02 (2006.01); A61K 47/36 (2006.01); A61K 47/12 (2006.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01); A61P 35/00 (2018.01);
Abstract
Substituted -3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and related compounds, which are useful as inhibitors of ENPP1; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds and compositions to treat disorders associated with dysfunction of the ENPP1.